X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Religare Enterprises with Indoco Remedies - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RELIGARE ENT. vs INDOCO REMEDIES - Comparison Results

RELIGARE ENT.    Change

Promoted by Mr. Malvinder Mohan Singh and Mr. Shivinder Mohan Singh , Religare Enterprises is a financial services company, offering a wide range of financial products and services targeted at retail investors, high net worth individuals and corporat... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RELIGARE ENT. INDOCO REMEDIES RELIGARE ENT./
INDOCO REMEDIES
 
P/E (TTM) x 17.5 31.0 56.6% View Chart
P/BV x 0.2 3.7 6.8% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 RELIGARE ENT.   INDOCO REMEDIES
EQUITY SHARE DATA
    RELIGARE ENT.
Mar-16
INDOCO REMEDIES
Mar-17
RELIGARE ENT./
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs395360 109.6%   
Low Rs256249 102.8%   
Sales per share (Unadj.) Rs218.0119.0 183.1%  
Earnings per share (Unadj.) Rs-2.38.4 -28.0%  
Cash flow per share (Unadj.) Rs-0.615.2 -3.8%  
Dividends per share (Unadj.) Rs01.60 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs190.070.7 268.7%  
Shares outstanding (eoy) m203.3392.15 220.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.52.6 58.3%   
Avg P/E ratio x-138.936.4 -381.1%  
P/CF ratio (eoy) x-561.020.0 -2,803.6%  
Price / Book Value ratio x1.74.3 39.8%  
Dividend payout %019.1 0.0%   
Avg Mkt Cap Rs m66,18428,083 235.7%   
No. of employees `000NA6.0 0.0%   
Total wages/salary Rs m9,3362,167 430.9%   
Avg. sales/employee Rs ThNM1,817.0-  
Avg. wages/employee Rs ThNM359.0-  
Avg. net profit/employee Rs ThNM127.7-  
INCOME DATA
Net Sales Rs m44,31810,968 404.1%  
Other income Rs m70940 1,784.6%   
Total revenues Rs m45,02611,007 409.1%   
Gross profit Rs m23,7231,565 1,516.2%  
Depreciation Rs m359633 56.7%   
Interest Rs m18,72162 30,147.2%   
Profit before tax Rs m5,351909 588.4%   
Minority Interest Rs m-1,0850-   
Prior Period Items Rs m60-   
Extraordinary Inc (Exp) Rs m-2,5330-   
Tax Rs m2,215139 1,597.1%   
Profit after tax Rs m-477771 -61.8%  
Gross profit margin %53.514.3 375.2%  
Effective tax rate %41.415.3 271.4%   
Net profit margin %-1.17.0 -15.3%  
BALANCE SHEET DATA
Current assets Rs m94,9575,725 1,658.7%   
Current liabilities Rs m103,0365,454 1,889.1%   
Net working cap to sales %-18.22.5 -738.6%  
Current ratio x0.91.0 87.8%  
Inventory Days Days562 7.6%  
Debtors Days Days3872 53.2%  
Net fixed assets Rs m17,8905,307 337.1%   
Share capital Rs m2,033184 1,103.3%   
"Free" reserves Rs m33,9996,331 537.0%   
Net worth Rs m38,6296,516 592.9%   
Long term debt Rs m118,5831,323 8,962.5%   
Total assets Rs m274,29311,970 2,291.6%  
Interest coverage x1.315.6 8.2%   
Debt to equity ratio x3.10.2 1,511.7%  
Sales to assets ratio x0.20.9 17.6%   
Return on assets %6.77.0 95.6%  
Return on equity %-1.211.8 -10.4%  
Return on capital %13.012.4 105.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m04,507 0.0%   
Fx outflow Rs m121,141 1.0%   
Net fx Rs m-123,366 -0.4%   
CASH FLOW
From Operations Rs m-21,540886 -2,430.1%  
From Investments Rs m5,149-1,706 -301.9%  
From Financial Activity Rs m18,5311,316 1,408.4%  
Net Cashflow Rs m2,139497 430.8%  

Share Holding

Indian Promoters % 50.9 59.2 86.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.9 12.5 7.2%  
FIIs % 15.3 6.0 255.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 32.9 22.4 146.9%  
Shareholders   26,518 12,805 207.1%  
Pledged promoter(s) holding % 68.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RELIGARE ENT. With:   STC INDIA  MOTILAL OSWAL  ADANI PORTS & SEZ  KOTHARI PRODUCTS  CHOLAMANDALAM INVEST.  



Today's Market

Of Mr Modi Providing Impetus to Defense Industry and Key Stocks in Action Today(Pre-Open)

Addressing the Uttar Pradesh Investors Summit, Mr. Modi announced the creation of a defense industrial corridor in Bundelkhand.

Related Views on News

Shriram Trans Fin: Expansion on Track Driven by Brisk Demand and Strong Earnings (Quarterly Results Update - Detailed)

Feb 16, 2018

Shriram Transport Finance puts up a strong performance on robust demand and falling credit costs.

HDFC: Listing Gains Mask Healthy Growth and Asset Quality (Quarterly Results Update - Detailed)

Feb 7, 2018

Windfall listing gains utilised to shore up provisions and strengthen balance sheet further.

Shriram Trans Fin: On a Strong Footing Despite IDFC Merger on Hold (Quarterly Results Update - Detailed)

Nov 22, 2017

Shriram Transport Finance posts strong earnings growth backed by revival in lending business and lower cost of funds.

HDFC: Gains from Insurance Subsidiary a Shot in the Arm (Quarterly Results Update - Detailed)

Nov 13, 2017

Listing gains from insurance subsidiary to boost HDFC's earnings in FY18.

Reliance Nippon Life Asset Management Company Ltd. (IPO)

Oct 24, 2017

Should you subscribe to the IPO of Reliance Nippon Life Asset Management Company Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

RELIGARE ENT. SHARE PRICE


Feb 22, 2018 09:01 AM

TRACK RELIGARE ENT.

  • Track your investment in RELIGARE ENT. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RELIGARE ENT. - COMMEX TECHNOLOGY COMPARISON

COMPARE RELIGARE ENT. WITH

MARKET STATS